SCHEMBL7415431

SCHEMBL7415431

C(=C\c1ccccc1)\CC1CCCN1CC1CC1

nearest known ligand 0.47

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 8/20 0.47
HTR2A P28223 5/20 0.47
HTR2C P28335 5/20 0.47
HTR2B P41595 5/20 0.47
KDM4E B2RXH2 1/20 0.38
LSS P48449 1/20 0.37
HRH3 Q9Y5N1 1/20 0.37
DRD2 P14416 1/20 0.36
ALDH1A1 P00352 2/20 0.36
CHRNB1 P11230 1/20 0.36
CHRNB2 P17787 1/20 0.36
CHRNB4 P30926 1/20 0.36
CHRNA3 P32297 1/20 0.36
CHRNB3 Q05901 1/20 0.36
MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7078128 1.00 SIGMAR1 (0.47) SIGMAR1HTR2AHTR2CHTR2BKDM4E
SCHEMBL7078706 1.00 SIGMAR1 (0.47) SIGMAR1HTR2AHTR2CHTR2BKDM4E
SCHEMBL7078708 1.00 SIGMAR1 (0.47) SIGMAR1HTR2AHTR2CHTR2BKDM4E
SCHEMBL7078130 1.00 SIGMAR1 (0.47) SIGMAR1HTR2AHTR2CHTR2BKDM4E
SCHEMBL7409859 0.96 SIGMAR1 (0.43) SIGMAR1HTR2AHTR2CHTR2BKDM4E
SCHEMBL7414839 0.96 SIGMAR1 (0.46) SIGMAR1HTR2AHTR2CHTR2BKDM4E
SCHEMBL7410376 0.96 SIGMAR1 (0.46) SIGMAR1HTR2AHTR2CHTR2BKDM4E
SCHEMBL7407659 0.96 SIGMAR1 (0.46) SIGMAR1HTR2AHTR2CHTR2BKDM4E
SCHEMBL7409858 0.96 SIGMAR1 (0.43) SIGMAR1HTR2AHTR2CHTR2BKDM4E
Hydrochloric Acid SCHEMBL467326 0.94 SIGMAR1 (0.42) SIGMAR1HTR2AHTR2CHTR2BKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0734379-B1 2-ARYLALKENYL-AZACYCLOALKANE DERIVATIVES AS SIGMA RECEPTOR LIGANDS, PREPARATION METHOD THEREFOR AND THERAPEUTICAL USE THEREOF PARKE DAVIS (FR) 2001-03-07 EP claimed
US-6013656-A PSYCHOLOGICAL DISORDERS; GASTROINTESTINAL DISORDERS; NERVOUSSYSTEM DISORDERS WARNER-LAMBERT COMPANY (US) 2000-01-11 US claimed
EP-0734379-B1 2-ARYLALKENYL-AZACYCLOALKANE DERIVATIVES AS SIGMA RECEPTOR LIGANDS, PREPARATION METHOD THEREFOR AND THERAPEUTICAL USE THEREOF PARKE DAVIS (FR) 2001-03-07 EP disclosed
EP-0995436-A2 Ligands for sigma receptors and their therapeutical applications PARKE-DAVIS (FR) 2000-04-26 EP disclosed
US-6013656-A PSYCHOLOGICAL DISORDERS; GASTROINTESTINAL DISORDERS; NERVOUSSYSTEM DISORDERS WARNER-LAMBERT COMPANY (US) 2000-01-11 US disclosed
US-5849760-A 2-(arylalkenyl)azacycloalkane derivatives as ligands for sigma receptors INSTITUT DE RECHERCHE JOUVEINAL (FR) 1998-12-15 US disclosed
WO-1995015948-A1 NOVEL 2-ARYLALKENYL-AZACYCLOALKANE DERIVATIVES AS SIGMA RECEPTOR LIGANDS, PREPARATION METHOD THEREFOR AND THERAPEUTICAL USE THEREOF INSTITUT DE RECHERCHE JOUVEINAL (FR) 1995-06-15 WO disclosed